Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|January 1, 1986
Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studiesL J Scully, A M Lever, I Yap, et al.
The Journal of Infection|November 1, 1995
Treatment of native valve Candida endocarditis with fluconazoleC J Wells, G J Leech, A M Lever, et al.
Clinical and Experimental Immunology|February 1, 1987
Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.
Infection|January 1, 1987
A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response ratesH C Thomas, L J Scully, A M Lever, et al.
Nucleic Acids Research|February 5, 2013
Expanding probe repertoire and improving reproducibility in human genomic hybridizationStephanie N Dorman, Ben C Shirley, Joan H M Knoll, et al.
Journal of Virological Methods|April 20, 2001
Chromosomal positioning of human T-lymphotropic type 1 proviruses by fluorescence in situ hybridisationJ H Richardson, N J Rose, S Mann, et al.
Virology|September 7, 2001
Sequences in the 5' leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell linesF M Guesdon, J Greatorex, S R Rhee, et al.
Blood|May 1, 1997
Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type IJ H Richardson, P Höllsberg, A Windhagen, et al.
Journal of Medical Virology|January 1, 1988
Presence of a partially acid-labile alpha-interferon in bronchoalveolar lavage fluid of patients with cytomegalovirus pneumonitis is associated with a poor prognosisA M Lever, H J Milburn, R M du Bois, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1987
Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomasM G Brook, A A Dunk, J A McDonald, et al.
Pageof 7